Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;30(6):846-853.
doi: 10.1177/15910199241285504. Epub 2024 Oct 3.

Silk vista baby flow diversion beyond the circle of Willis: A single-center experience with long-term outcomes

Affiliations

Silk vista baby flow diversion beyond the circle of Willis: A single-center experience with long-term outcomes

Natália Vasconcellos de Oliveira Souza et al. Interv Neuroradiol. 2024 Dec.

Abstract

Introduction: There is a lack of evidence of flow diversion (FD) safety for aneurysms treatment beyond the circle of Willis. Therefore, we provide a single-center real-world experience with the Silk Vista Baby (SVB).

Methods: A single-center database was retrospectively reviewed for aneurysms treated with SVB flow diverters. Demographic information, clinical presentation, radiographic characteristics, procedural complications, and outcomes were assessed.

Results: About 57 patients (66.7% female, mean age 54.3 ± 13.2) encompassing 57 aneurysms were included. Overall, 40.4% were ruptured: 68.4% saccular, 17.5% blister, 8.7% fusiform, and 5.3% dissecting. The majority were in the anterior circulation (68.4%), and in 48.2% of cases, the distal vessel diameter was inferior to 2 mm. The symptomatic ischemic rate was 5.2%, with one case due to in-stent thrombosis (1.8%). There were no hemorrhagic complications. Complication rates did not differ between ruptured and unruptured lesions (p = 0.356). There were no cases of delayed aneurysm rupture, and overall mortality was 1.8%. The median follow-up time was 18 ± 12 months. In-stent stenosis rate was 10.5% (6/57), all of which were asymptomatic. At the last follow-up, 70.2% of cases had an adequate occlusion (OKM C and D), and 96.5% had an mRS of 0-2.

Conclusion: In our series, SVB was shown to be a safe device in the treatment of not only distal anterior circulation aneurysms but also in the management of complex posterior fossa and ruptured blister aneurysms. Multicenter studies are needed to confirm and generalize these results.

Keywords: Silk vista baby; blister aneurysms; complex aneurysms; distal aneurysms; subarachnoid hemorrhage.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
A 58-year-old patient presented with a partially thrombosed (1A) left posterior inferior cerebellar aneurysm (PICA) causing right hemisensory loss, dysphagia, and left ataxia. Digital subtraction angiography (DSA) shows a partially thrombosed (1A) left posterior inferior cerebellar aneurysm (PICA). 3D DSA reconstruction from the left vertebral artery (1B) and a profile DSA (1C) show a left PICA dissecting fusiform aneurysm. A balloon test occlusion didn't evidence good collateral flow and a flow diverter strategy was then chosen. 1D: non - subtracted DSA showing the deployment of two SVB devices (2.25 × 20 mm and 2.5 × 20 mm) across the entire aneurysm neck. 1E: post-deployment profile angiography. 1F: vaso-CT showing the distal end of the stent in the true vessel lumen, surrounded by the partially thrombosed aneurysm (false lumen). 1G: vaso-CT showing the proximal end of the stent, well apposed to the vessel wall. 1H: 6-month MRI control shows no longer a thrombosed aneurysm compressing the brainstem and the cerebellum. 1I: 6-month DSA 3D reconstruction from the left vertebral artery showing patency and reconstruction of the left PICA.

References

    1. Kallmes DF, Brinjikji W, Cekirge S, et al. Safety and efficacy of the pipeline embolization device for treatment of intracranial aneurysms: a pooled analysis of 3 large studies. J Neurosurg 2017; 127: 775–780. - PubMed
    1. Hanel RA, Kallmes DF, Lopes DK, et al. Prospective study on embolization of intracranial aneurysms with the pipeline device: the PREMIER study 1 year results. J Neurointerv Surg 2020; 12: 62–66. - PMC - PubMed
    1. Enriquez-Marulanda A, Penumaka A, Ogilvy CS, et al. Safety and efficacy of the off-label use of pipeline embolization device based on the 2018 food and drug administration-approved indications for intracranial aneurysms: a single-center retrospective cohort study. Neurosurgery 2022; 90: 700–707. - PubMed
    1. Shehata MA, Ibrahim MK, Ghozy S, et al. Long-term outcomes of flow diversion for unruptured intracranial aneurysms: a systematic review and meta-analysis. J Neurointerv Surg 2023; 15: 898–902. - PMC - PubMed
    1. Hanel RA, Cortez GM, Lopes DK, et al. Prospective study on embolization of intracranial aneurysms with the pipeline device (PREMIER study): 3-year results with the application of a flow diverter specific occlusion classification. J Neurointerv Surg 2023; 15: 248–254. - PMC - PubMed

LinkOut - more resources